A Pityrosporum Fungal Infection Following Infliximab Therapy in a Crohn's Disease Patient.
- Author:
Keun Young SHIN
1
;
Jun HEO
;
Min Kyu JUNG
;
Seong Woo JEON
;
Sung Kook KIM
Author Information
- Publication Type:Case Report
- Keywords: Crohn Disease; Infliximab; Pityriasis Versicolor
- MeSH: Antibodies, Monoclonal; Crohn Disease; Humans; Infliximab; Ketoconazole; Malassezia; Necrosis; Tinea Versicolor
- From:Intestinal Research 2010;8(2):177-180
- CountryRepublic of Korea
- Language:English
- Abstract: Crohn's disease (CD) is a chronic immune-mediated inflammatory disorder. Treatment strategies for CD are targeted toward various components of the proinflammatory mediators and subsequent immune response. Recently, the anti-tumor necrosis factor (TNF) monoclonal antibody, infliximab has been used in patients with CD. However, uncommon and unusual infections have been reported during anti-TNF-alpha therapy and immunomodulator. Here, we report a case of pityriasis versicolor occurring in a patient with CD receiving infliximab treatment. The patient was successfully treated with topical ketoconazole.
